Nasdaq Fdmt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq fdmt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Fdmt Today - Breaking & Trending Today

Brokerages Set 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) PT at $44.22

Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) have been given an average rating of “Buy” by the ten research firms that are presently covering the firm, MarketBeat.com reports. Ten investment analysts have rated the stock with a buy recommendation. The average 1-year price objective among brokerages that have issued ratings on […] ....

United States , Robert Young Kim , Scott Bizily , Goldman Sachs Group , D Molecular Therapeutics Inc , China Universal Asset Management Co , Royal Bank , Principal Financial Group Inc , Daiwa Securities Group Inc , Allspring Global Investments Holdings , Securities Exchange Commission , Molecular Therapeutics , Get Free Report , Molecular Therapeutics Price , Exchange Commission , Universal Asset Management , Global Investments Holdings , Securities Group , Principal Financial Group , Get Free , Molecular Therapeutics Daily , 4d Molecular Therapeutics , Nasdaq Fdmt ,

Brokerages Set 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Target Price at $44.22

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) has received an average recommendation of “Buy” from the ten analysts that are covering the company, MarketBeat reports. Ten investment analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have covered the stock in the last year […] ....

United States , Robert Young Kim , Scott Bizily , Vontobel Holding Ltd , Jefferies Financial Group , Royal Bank , D Molecular Therapeutics Company Profile , Goldman Sachs Group Inc , Securities Exchange Commission , Goldman Sachs Group , Sectoral Asset Management Inc , D Molecular Therapeutics Inc , Molecular Therapeutics , Get Free Report , Exchange Commission , Sachs Group , Sectoral Asset Management , Molecular Therapeutics Price , Molecular Therapeutics Company , Get Free , Molecular Therapeutics Daily , 4d Molecular Therapeutics , Nasdaq Fdmt ,

Bfsg LLC Takes Position in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT)

Bfsg LLC acquired a new stake in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) during the fourth quarter, Holdings Channel reports. The institutional investor acquired 1,500 shares of the company’s stock, valued at approximately $30,000. A number of other hedge funds have also recently modified their holdings of FDMT. RA Capital Management L.P. boosted […] ....

United States , Dekabank Deutsche Girozentrale , Scott Bizily , David Kirn , Goldman Sachs Group , Vontobel Holding Ltd , Royal Bank , Holdings Channel , Panagora Asset Management Inc , D Molecular Therapeutics Inc , Jefferies Financial Group , Molecular Therapeutics , Free Report , Asset Management , Bank Deutsche Girozentrale , Trexquant Investment , Molecular Therapeutics Stock Down , Get Free Report , Visit Holdingschannel , Molecular Therapeutics Daily , 4d Molecular Therapeutics , Nasdaq Fdmt , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Bfsg LLC Acquires New Position in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT)

Bfsg LLC acquired a new stake in shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 1,500 shares of the company’s stock, valued at approximately $30,000. A number of other institutional investors and hedge funds […] ....

United States , David Kirn , Scott Bizily , Panagora Asset Management Inc , Mt Bank Corp , T Bank Corp , Sg Americas Securities , D Molecular Therapeutics Inc , Jefferies Financial Group , Goldman Sachs Group , York Mellon Corp , Affinity Wealth Management , Molecular Therapeutics , Free Report , Wealth Management , New York Mellon Corp , Asset Management , Financial Group , Molecular Therapeutics Trading Down , Get Free Report , Molecular Therapeutics Daily , 4d Molecular Therapeutics , Nasdaq Fdmt , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

4D Molecular Therapeutics (NASDAQ:FDMT) Shares Down 2.3%

Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) were down 2.3% during trading on Wednesday . The company traded as low as $26.13 and last traded at $26.13. Approximately 43,923 shares were traded during mid-day trading, a decline of 96% from the average daily volume of 1,080,685 shares. The stock had previously […] ....

Nova Scotia , United States , Scott Bizily , David Kirn , Novo Holdings , Securities Exchange Commission , D Molecular Therapeutics Inc , Blackrock Inc , Goldman Sachs Group Inc , Jefferies Financial Group , Royal Bank , Molecular Therapeutics , Get Free Report , Financial Group , Molecular Therapeutics Trading Down , Exchange Commission , Street Corp , Sachs Group , Molecular Therapeutics Daily , 4d Molecular Therapeutics , Nasdaq Fdmt ,